Literature DB >> 7837126

Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.

T Ashraf1, S B Arnold, M Maxfield.   

Abstract

The objective of this analysis was to evaluate and compare the cost-effectiveness of eight contraceptive methods: condoms, diaphragms, oral contraceptives, intrauterine devices, medroxyprogesterone acetate suspension, levonorgestrel subdermal implants, tubal ligation and vasectomy. Based on a comprehensive review of the literature and various additional data sources, this analysis identified, measured and compared direct costs of the methods, physician visits, treatment of adverse effects and cost of failure (i.e., mean cost for all types of deliveries or first-trimester abortion). Medical benefits (if any) resulting from each contraceptive method were calculated and considered in the analysis as cost savings. The cost of method failure proved to be the greatest influence on cost-effectiveness. Sterilization was identified as the most cost-effective method overall. Of the reversible methods, the intrauterine device was found to be the most cost-effective, followed by levonorgestrel implants.

Entities:  

Keywords:  Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Implants; Contraceptive Methods; Cost Effectiveness; Data Analysis; Developed Countries; Evaluation Indexes; Family Planning; Iud; Levonorgestrel; North America; Northern America; Quantitative Evaluation; Research Report; Sterilization, Sexual; United States

Mesh:

Substances:

Year:  1994        PMID: 7837126

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  Failing to prevent unintended pregnancy is costly.

Authors:  P R Lee; F H Stewart
Journal:  Am J Public Health       Date:  1995-04       Impact factor: 9.308

Review 2.  Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

Authors:  A J Coukell; J A Balfour
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

Review 3.  Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Authors:  Irving Sivin
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda.

Authors:  Laura Di Giorgio; Mercy Mvundura; Justine Tumusiime; Chloe Morozoff; Jane Cover; Jennifer Kidwell Drake
Journal:  Contraception       Date:  2018-08-09       Impact factor: 3.375

5.  Development of a pharmacoeconomic registry: an example using hormonal contraceptives.

Authors:  Annesha White; Meenakshi Srinivasan; La Marcus Wingate; Samuel Peasah; Marc Fleming
Journal:  Health Econ Rev       Date:  2021-03-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.